Robert Lofberg

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies.

Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies.

Journal: Journal of Crohn's & colitis

Published: May 22, 2018

Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn's Disease: A Pooled Analysis of 11 Clinical Studies.

Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn's Disease: A Pooled Analysis of 11 Clinical Studies.

Journal: Advances in therapy

Published: December 04, 2017

Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients.

Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients.

Journal: Alimentary pharmacology & therapeutics

Published: August 24, 2016

HLA Associations Distinguish Collagenous From Lymphocytic Colitis.

HLA Associations Distinguish Collagenous From Lymphocytic Colitis.

Journal: The American journal of gastroenterology

Published: August 03, 2016

Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.

Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.

Journal: European journal of gastroenterology & hepatology

Published: July 30, 2016

Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis.

Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis.

Journal: Journal of Crohn's & colitis

Published: January 11, 2016

Microscopic colitis: a descriptive clinical cohort study of 795 patients with collagenous and lymphocytic colitis.

Microscopic colitis: a descriptive clinical cohort study of 795 patients with collagenous and lymphocytic colitis.

Journal: Scandinavian journal of gastroenterology

Published: December 19, 2015

Healthcare Utilisation and Drug Treatment in a Large Cohort of Patients with Inflammatory Bowel Disease.

Healthcare Utilisation and Drug Treatment in a Large Cohort of Patients with Inflammatory Bowel Disease.

Journal: Journal of Crohn's & colitis

Published: August 20, 2015

Dense genotyping of immune-related loci identifies HLA variants associated with increased risk of collagenous colitis.

Dense genotyping of immune-related loci identifies HLA variants associated with increased risk of collagenous colitis.

Journal: Gut

Published: May 07, 2015

Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial.

Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial.

Journal: Gut

Published: September 01, 2014

Biomarkers can predict potential clinical responders to DIMS0150 a toll-like receptor 9 agonist in ulcerative colitis patients.

Biomarkers can predict potential clinical responders to DIMS0150 a toll-like receptor 9 agonist in ulcerative colitis patients.

Journal: BMC gastroenterology

Published: November 15, 2013

Exploring anorectal manometry as a method to study the effect of locally administered ropivacaine in patients with ulcerative colitis.

Exploring anorectal manometry as a method to study the effect of locally administered ropivacaine in patients with ulcerative colitis.

Journal: ISRN gastroenterology

Published: December 20, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026